NOS is the a national charity dedicated to improving the prevention, diagnosis, and treatment of this fragile bone disease.
Pfizer supported the NOS 2007 conference and also provided a donation to support a range of projects including access to the NOS helpline; awareness campaigns; expanding the NOS network and NICE guidance development.
£17,000
As a guide this amount represents less than 1% of the total income of NOS based on their last declared financial year (January 2006-December 2006).